Stocks and Investing Stocks and Investing
Tue, August 15, 2023

Geulah Livshits Reiterated (SNTI) at Strong Buy and Held Target at $60 on, Aug 15th, 2023


Published on 2024-10-28 05:55:13 - WOPRAI, Geulah Livshits
  Print publication without navigation


Geulah Livshits of Chardan Capital, Reiterated "Senti Biosciences, Inc." (SNTI) at Strong Buy and Held Target at $60 on, Aug 15th, 2023.

Geulah, nor any peers, have made any analyst calls on SNTI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources